Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hatef Massoumi

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Clinical Gastroenterology|April 12, 2007
Bile leak after laparoscopic cholecystectomyHatef Massoumi, Nejat Kiyici, Hilary Hertan
European Journal of Gastroenterology & Hepatology|May 24, 2011
Management of chronic hepatitis BHatef Massoumi, Paul Martin, Hui-Hui Tan
Gastroenterology and Hepatology From Bed to Bench|July 27, 2016
Clinical characteristics and response to therapy of autoimmune hepatitis in an urban Latino populationAyesha Zahiruddin, Abtin Farahmand, Paul Gaglio, et al.
Gastroenterology and Hepatology From Bed to Bench|April 18, 2023
Granulocyte colony-stimulating factor does not improve mortality in severe alcoholic hepatitis: a single-center experience from the United StatesJonathan Nahas, Clara Y Tow, Kristina R Chacko, et al.
Clinical Case Reports|June 8, 2017
Ibrutinib-induced severe liver injuryAmara G Nandikolla, Olga Derman, Deborah Nautsch, et al.
Transplantation|September 11, 2009
An escalating dose regimen of pegylated interferon and ribavirin in HCV cirrhotic patients referred for liver transplantHatef Massoumi, Hussein Elsiesy, Viktoriya Khaitova, et al.
Hepatology (Baltimore, Md.)|January 6, 2010
Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patientsPaul Feuerstadt, Ari L Bunim, Heriberto Garcia, et al.
Therapeutic Advances in Gastroenterology|September 2, 2015
The impact of an educational program on HCV patient outcomes using boceprevir in community practices (OPTIMAL trial)Fred Poordad, Vinod Rustgi, Robert S Brown, et al.
Hepatitis Monthly|November 2, 2016
Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National GuidelineSeyed Moayed Alavian, Behzad Hajarizadeh, Kamran Bagheri Lankarani, et al.
Journal of Autoimmunity|September 11, 2022
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitisCumali Efe, Koray Taşçılar, Alessio Gerussi, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Clinical Gastroenterology|April 12, 2007
Bile leak after laparoscopic cholecystectomyHatef Massoumi, Nejat Kiyici, Hilary Hertan
European Journal of Gastroenterology & Hepatology|May 24, 2011
Management of chronic hepatitis BHatef Massoumi, Paul Martin, Hui-Hui Tan
Gastroenterology and Hepatology From Bed to Bench|July 27, 2016
Clinical characteristics and response to therapy of autoimmune hepatitis in an urban Latino populationAyesha Zahiruddin, Abtin Farahmand, Paul Gaglio, et al.
Gastroenterology and Hepatology From Bed to Bench|April 18, 2023
Granulocyte colony-stimulating factor does not improve mortality in severe alcoholic hepatitis: a single-center experience from the United StatesJonathan Nahas, Clara Y Tow, Kristina R Chacko, et al.
Clinical Case Reports|June 8, 2017
Ibrutinib-induced severe liver injuryAmara G Nandikolla, Olga Derman, Deborah Nautsch, et al.
Transplantation|September 11, 2009
An escalating dose regimen of pegylated interferon and ribavirin in HCV cirrhotic patients referred for liver transplantHatef Massoumi, Hussein Elsiesy, Viktoriya Khaitova, et al.
Hepatology (Baltimore, Md.)|January 6, 2010
Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patientsPaul Feuerstadt, Ari L Bunim, Heriberto Garcia, et al.
Therapeutic Advances in Gastroenterology|September 2, 2015
The impact of an educational program on HCV patient outcomes using boceprevir in community practices (OPTIMAL trial)Fred Poordad, Vinod Rustgi, Robert S Brown, et al.
Hepatitis Monthly|November 2, 2016
Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National GuidelineSeyed Moayed Alavian, Behzad Hajarizadeh, Kamran Bagheri Lankarani, et al.
Journal of Autoimmunity|September 11, 2022
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitisCumali Efe, Koray Taşçılar, Alessio Gerussi, et al.
Pageof 2